First‐in‐human trial assessing the pharmacokinetic‐pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age-Reference-Cited by-同舟云学术

First‐in‐human trial assessing the pharmacokinetic‐pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age

Published:2021-06-21 Issue:4 Volume:14 Page:1590-1599
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Broksø Kyhl Lars‐Erik¹,Hesse Christiane¹,Larsson Per²,Bruzelius Katharina³,Mannaerts Bernadette⁴

Affiliation:

1. Translational Medicine and Clinical Pharmacology Ferring Pharmaceuticals A/S Copenhagen Denmark

2. Global Biometrics Ferring Pharmaceuticals A/S Copenhagen Denmark

3. Department of Bioanalysis Ferring Pharmaceuticals A/S Copenhagen Denmark

4. Reproductive Medicine and Maternal Health Ferring Pharmaceuticals A/S Copenhagen Denmark

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13037

Reference26 articles.

1. Biological functions of hCG and hCG-related molecules

2. Pulsatile Secretion of Chorionic Gonadotropin during the Normal Menstrual Cycle*

3. Review: hCGs: Different sources of production, different glycoforms and functions

4. Intact HCG, free HCG β subunit and HCG β core fragment: longitudinal patterns in urine during early pregnancy

5. Historical perspectives in gonadotrophin therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy?;International Journal of Molecular Sciences;2023-05-19

2. A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes;Diagnostics;2023-01-04

3. The effect of a single escalating dose of long-acting recombinant human follicle-stimulating hormone Fc fusion protein (KN015) on healthy, pituitary-suppressed women: first-in-human and randomized study on its pharmacokinetics, pharmacodynamics, and tolerability;Expert Opinion on Investigational Drugs;2022-11-02

4. Dose-dependent stimulation of human follicular steroidogenesis by a novel rhCG during ovarian stimulation with fixed rFSH dosing;Frontiers in Endocrinology;2022-10-20

5. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol;Human Reproduction;2022-04-22